首页> 外文OA文献 >Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantion in elderly patients and association with acute graft-versus-host disease
【2h】

Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantion in elderly patients and association with acute graft-versus-host disease

机译:CD25耗竭同种异体移植后老年患者中FOXP3 +调节性T细胞(Tregs)的重建,并与急性移植物抗宿主病相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Selective depletion (SD) of host-reactive donor T cells from allogeneic stem-cell transplants (SCTs) using an anti-CD25 immunotoxin (IT) is a strategy to prevent acute graft-versus-host disease (aGvHD). There is concern that concurrent removal of regulatory T cells (Tregs) with incomplete removal of alloactivated CD25+ T cells could increase the risk of aGvHD. We therefore measured Tregs in the blood of 16 patients receiving a T-cell–depleted allograft together with anti–CD25-IT–treated SD lymphocytes, in 13 of their HLA-identical donors, and in 10 SD products. Tregs were characterized by intracellular staining for forkhead box protein 3 (FOXP3) and by quantitative reverse-transcription–polymerase chain reaction (qRT-PCR) for FOXP3 gene in CD4+ cells. Patients received a median of 1.0 × 108/kg SD T cells and a stem cell product containing a median of 0.25 × 104/kg residual T cells. Tregs reconstituted promptly after SCT and underwent further expansion. Of the CD4+ T cells in SD products, 1.5% to 4.8% were CD25− Tregs. Acute GvHD (≥ grade II) was restricted to 5 patients whose donors had significantly (P = .019) fewer Tregs compared with those without clinically significant aGvHD. These results suggest that rapid Treg reconstitution can occur following SD allografts, either from CD25− Tregs escaping depletion, or from residual CD25− and CD25+ Tregs contained in the stem-cell product that expand after transplantation and may confer additional protection against GvHD.
机译:使用抗CD25免疫毒素(IT)从同种异体干细胞移植(SCT)中选择性清除宿主反应性供体T细胞(SD)是预防急性移植物抗宿主病(aGvHD)的策略。令人担忧的是,同时去除调节性T细胞(Tregs)和不完全去除同种活化的CD25 + T细胞可能会增加aGvHD的风险。因此,我们测量了16名接受T细胞清除同种异体移植以及抗CD25-IT治疗的SD淋巴细胞,13名相同的HLA供体和10种SD产品的血液中的Treg。 Tregs的特征是细胞内的叉头盒蛋白3(FOXP3)染色和CD4 +细胞中FOXP3基因的定量逆转录聚合酶链反应(qRT-PCR)。患者接受的中位数为1.0×108 / kg SD T细胞,干细胞产物中位数为0.25×104 / kg残余T细胞。在SCT之后,Tregs迅速恢复原状并进一步扩展。 SD产品中的CD4 + T细胞中,CD25- Tregs为1.5%至4.8%。急性GvHD(≥II级)仅限于5例患者,其供体的Treg显着低于(P = .019)无临床意义的aGvHD的患者。这些结果表明,SD同种异体移植后,快速的Treg重组可能发生,这可能是由于CD25- Treg逃逸而引起的,也可能是干细胞产品中残留的CD25-和CD25 + Treg的残留,这些CD25-和CD25 + Treg在移植后会扩张,并可能赋予针对GvHD的额外保护。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号